Aprinoia Therapeutics Company
Biotechnology, Neuorscience
Last Funding Type:
Series C
Funding Status:
Late Stage Venture
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2015-05-20
Last Funding Date:
2021-12-28
Total Funding:
57530000.0
Estimated Revenue:
$1M to $10M
Investors Number:
8.0
Industry:
Neuroimaging